‘The Paxman hair loss prevention system can be your solution to prevent chemotherapy induced hair loss.’

Our Clinical Efficacy brochure provides an overall summary of effectiveness and tolerance of the Paxman Scalp Cooling System.

Independent observational studies have demonstrated the effectiveness of the Paxman Scalp Cooling System in the prevention of chemotherapy induced hair loss with widely used chemotherapy dosages and regimens.

High levels of comfort and patient acceptability were reported in all trials, with low numbers of patients discontinuing scalp cooling, even when post-infusion cooling extended for 2.5 hours.

Our Clinical Efficacy brochure which details the results of 5 different studies carried out using the Paxman Hair Loss Prevention System, is available to download in full below.